Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 Study

NCT03820063 is registered in ClinicalTrials.gov with Borstkanker Onderzoek Groep as lead sponsor.

NCT NCT03820063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03820063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 Study
Lead sponsor
Borstkanker Onderzoek Groep
Phase
Phase 2
Overall status
Active, not recruiting
Start date
February 27, 2019
Completion date
May 1, 2032
Enrollment
462 (estimated)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer